RAC1 and ovarian cancer: To clarify the carcinogenic effect of ESRP1 in ovarian cancer, we found that ESRP1 inhibited cancer cell migration and invasion by alternatively splicing cytoskeleton-associated proteins Rac1 and EPB41L5, and promoted colonization and colony formation.